Legend BiotechCorp EBITDA vs. Z Score
| LEGN Stock | USD 47.45 0.39 0.83% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -421.8 M | Current Value -442.9 M | Quarterly Volatility 189.4 M |
For Legend BiotechCorp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Legend BiotechCorp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Legend BiotechCorp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Legend BiotechCorp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Legend BiotechCorp over time as well as its relative position and ranking within its peers.
Legend |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Legend BiotechCorp Z Score vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Legend BiotechCorp's current stock value. Our valuation model uses many indicators to compare Legend BiotechCorp value to that of its competitors to determine the firm's financial worth. Legend BiotechCorp is rated below average in ebitda category among related companies. It is currently under evaluation in z score category among related companies . Legend BiotechCorp reported last year EBITDA of (421.76 Million). Comparative valuation analysis is a catch-all model that can be used if you cannot value Legend BiotechCorp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Legend BiotechCorp's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend BiotechCorp's earnings, one of the primary drivers of an investment's value.Legend Z Score vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Legend BiotechCorp |
| = | (421.76 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Legend BiotechCorp |
| = | null |
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Legend Z Score Comparison
Legend BiotechCorp is currently under evaluation in z score category among related companies.
Legend BiotechCorp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Legend BiotechCorp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Legend BiotechCorp will eventually generate negative long term returns. The profitability progress is the general direction of Legend BiotechCorp's change in net profit over the period of time. It can combine multiple indicators of Legend BiotechCorp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 98.9 M | 94 M | |
| Operating Income | -442.2 M | -420.1 M | |
| Income Before Tax | -520.1 M | -494.1 M | |
| Net Loss | -401.7 M | -381.6 M | |
| Net Loss | -518.3 M | -492.3 M | |
| Income Tax Expense | -1.9 M | -1.8 M | |
| Net Interest Income | 21.2 M | 22.3 M | |
| Interest Income | 42.1 M | 44.2 M | |
| Net Loss | -509.3 M | -483.8 M | |
| Total Other Income Expense Net | -77.9 M | -74 M | |
| Change To Netincome | 39.3 M | 55.1 M | |
| Net Loss | (2.94) | (3.09) | |
| Income Quality | 0.74 | 0.78 | |
| Net Income Per E B T | 1.00 | 1.23 |
Legend Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Legend BiotechCorp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Legend BiotechCorp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Legend BiotechCorp's important profitability drivers and their relationship over time.
Use Legend BiotechCorp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend BiotechCorp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend BiotechCorp will appreciate offsetting losses from the drop in the long position's value.Legend BiotechCorp Pair Trading
Legend BiotechCorp Pair Trading Analysis
The ability to find closely correlated positions to Legend BiotechCorp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend BiotechCorp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend BiotechCorp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend BiotechCorp to buy it.
The correlation of Legend BiotechCorp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend BiotechCorp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend BiotechCorp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend BiotechCorp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Legend BiotechCorp position
In addition to having Legend BiotechCorp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aircraft Thematic Idea Now
Aircraft
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
To fully project Legend BiotechCorp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Legend BiotechCorp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Legend BiotechCorp's income statement, its balance sheet, and the statement of cash flows.